FDA Inspection 1229905 — Robertson Microlit Laboratories, Inc.

Robertson Microlit Laboratories, Inc. — FEI 2246982

The FDA completed an inspection of Robertson Microlit Laboratories, Inc. on Jan 11, 2024 in Ledgewood, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Jan 11, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ledgewood, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.